Healthcare - Articles
The UK Government is at risk of missing its target to increase healthy life expectancy by five years by 2035, according to a new report, Growing Older, Better, published by The Physiological Society on Tuesday 15 October.
Healthy life expectancy, which is the number of years lived in good health, has not increased as quickly as life expectancy in recent decades, which means people are living more years in poor health. The UK Government’s Industrial Strategy contains a target of “ensur[ing] that people can enjoy at least five extra healthy, independent years of life by 2035, while narrowing the gap between the experience of the richest and poorest”. This new report, which is the result of a project involving an expert panel of researchers, funders and public health policy makers, outlines co…
Healthy life expectancy, which is the number of years lived in good health, has not increased as quickly as life expectancy in recent decades, which means people are living more years in poor health. The UK Government’s Industrial Strategy contains a target of “ensur[ing] that people can enjoy at least five extra healthy, independent years of life by 2035, while narrowing the gap between the experience of the richest and poorest”. This new report, which is the result of a project involving an expert panel of researchers, funders and public health policy makers, outlines co…
The severe side effects of conventional chemotherapeutic treatments can’t be ignored since in most cases, the valid drug dose that can remove the tumor are too toxic for patients. To solve the limitations, the antibody drug conjugates (ADCs) have emerged consisting of tumor-selective antibody-linked drugs, with the potential to significantly broaden the therapeutic range.
The severe side effects of conventional chemotherapeutic treatments can’t be ignored since in most cases, the valid drug dose that can remove the tumor are too toxic for patients. To solve the limitations, the antibody drug conjugates (ADCs) have emerged consisting of tumor-selective antibody-linked drugs, with the potential to significantly broaden the therapeutic range. Antibody-drug conjugates (ADCs), the focus o…
The severe side effects of conventional chemotherapeutic treatments can’t be ignored since in most cases, the valid drug dose that can remove the tumor are too toxic for patients. To solve the limitations, the antibody drug conjugates (ADCs) have emerged consisting of tumor-selective antibody-linked drugs, with the potential to significantly broaden the therapeutic range. Antibody-drug conjugates (ADCs), the focus o…
North America Dental Equipment Market Research Report By Product (Dental Radiology Equipment, Dental Hand Pieces, CAD/CAM), Application (Examining The Mouth & Teeth, Cavity Removal, Condensing Filling Materials), End User – Forecast To 2023
North American Dental Equipment Market Overview Over the last two hundred years, dentistry has made countless strides and also experienced a few setbacks globally. Though, the ultimate goal of the profession has always remained the same, which is to meet the treatment needs of the patient. Dental technology remains an important and valuable key to providing excellence in patient care. The role of today’s dental specialist has extended and evolved to being a gatekeeper of new product information, advisor on new restorative materials, imaging devices and…
North American Dental Equipment Market Overview Over the last two hundred years, dentistry has made countless strides and also experienced a few setbacks globally. Though, the ultimate goal of the profession has always remained the same, which is to meet the treatment needs of the patient. Dental technology remains an important and valuable key to providing excellence in patient care. The role of today’s dental specialist has extended and evolved to being a gatekeeper of new product information, advisor on new restorative materials, imaging devices and…
Investment in biotechnology has been on the rise for nearly a decade, with biotech startups raising just shy of 29 billion USD in 2018. For smart investors, due diligence is now a necessity, as it can make the difference between landing a possible billion-dollar blockbuster or a multi-million dollar dud.
In recent years the biotech and pharmaceutical industries have seen an unprecedented increase in investment. Both large pharma and investors are all searching for the next big thing to expand their portfolios and continue growth. Risk is high and a key part of mitigating this is effective due diligence. Simply put, due diligence is the investigation of a business or asset prior to signing a contract. As with any transaction, information is never perfect and the concept is that by conducting…
In recent years the biotech and pharmaceutical industries have seen an unprecedented increase in investment. Both large pharma and investors are all searching for the next big thing to expand their portfolios and continue growth. Risk is high and a key part of mitigating this is effective due diligence. Simply put, due diligence is the investigation of a business or asset prior to signing a contract. As with any transaction, information is never perfect and the concept is that by conducting…
More than 2,000 enzymes have been identified, and each enzyme is involved with one specific chemical reaction. Enzymes are therefore substrate-specific. They are grouped into a half-dozen classes on the basis of the kinds of reactions they take part in.
Enzymes are key protein molecules in living systems. Once synthesized, they are not usually converted to other kinds of molecules, and so are the substances taken in as fuel for digestive and respiratory processes (such as sugar, fat, and molecular oxygen). This is because enzymes are catalysts, which means they can participate in chemical reactions without themselves being changed, just like the moderator of a public debate who ideally moves the participants and the audience toward a conclusion by dictating the terms of the argument while n…
Enzymes are key protein molecules in living systems. Once synthesized, they are not usually converted to other kinds of molecules, and so are the substances taken in as fuel for digestive and respiratory processes (such as sugar, fat, and molecular oxygen). This is because enzymes are catalysts, which means they can participate in chemical reactions without themselves being changed, just like the moderator of a public debate who ideally moves the participants and the audience toward a conclusion by dictating the terms of the argument while n…
08-Oct-2019
Here are the top Pharma and Life Science recruitment organisations advertising in September on PharmiWeb.jobs.
Barrington James Clinical - 206 Jobs RBW Consulting - 163 Jobs i-Pharm Consulting - 141 Jobs CHASE - 133 Jobs SEC Recruitment - 116 Jobs ID Search & Selection - 86 Jobs Clinical Professionals Ltd - 85 Jobs Hobson Prior - 76 Jobs CK Clinical - 68 Jobs Barrington James Europe - 63 Jobs X4 Life Sciences - 63 Jobs Advanced Regulatory (UK & Europe) - 60 Jobs Barrington James Medical / Executive - 58 Jobs Thornshaw Recruitment - 56 Jobs Barrington James Scientific - 48 Jobs Only Medics Recruitment ltd - 46 Jobs Planet Pharma Staffing Limited - 45 Jobs Umbilical Life - 44 Jobs ProClinical Ltd - 39 Jobs CTC Resourcing Solutions - 34 Jobs Volt - 31 Jobs Haybury - 31 Jobs Advanced S…
Barrington James Clinical - 206 Jobs RBW Consulting - 163 Jobs i-Pharm Consulting - 141 Jobs CHASE - 133 Jobs SEC Recruitment - 116 Jobs ID Search & Selection - 86 Jobs Clinical Professionals Ltd - 85 Jobs Hobson Prior - 76 Jobs CK Clinical - 68 Jobs Barrington James Europe - 63 Jobs X4 Life Sciences - 63 Jobs Advanced Regulatory (UK & Europe) - 60 Jobs Barrington James Medical / Executive - 58 Jobs Thornshaw Recruitment - 56 Jobs Barrington James Scientific - 48 Jobs Only Medics Recruitment ltd - 46 Jobs Planet Pharma Staffing Limited - 45 Jobs Umbilical Life - 44 Jobs ProClinical Ltd - 39 Jobs CTC Resourcing Solutions - 34 Jobs Volt - 31 Jobs Haybury - 31 Jobs Advanced S…
08-Oct-2019
A list of the TOP Pharma Companies who are hiring this month (September)
Covance - 388 Jobs BSI Group - 167 Jobs PRA Health Sciences - 105 Jobs PPD- 81 Jobs Roche - 77 Jobs Synteract- 74 Jobs United BioSource Corporation. - 69 Jobs Cytel - 68 Jobs Syneos Health - 52 Jobs CROMSOURCE - 51 Jobs IQVIA - 36 Jobs AstraZeneca - 36 Jobs Celgene - 32 Jobs IQVIA Biotech - 21 Jobs Oxford BioMedica (UK) Limited - 16 Jobs Lonza - 16 Jobs Grunenthal GmbH - 14 Jobs Register and Upload Your CV Now
Covance - 388 Jobs BSI Group - 167 Jobs PRA Health Sciences - 105 Jobs PPD- 81 Jobs Roche - 77 Jobs Synteract- 74 Jobs United BioSource Corporation. - 69 Jobs Cytel - 68 Jobs Syneos Health - 52 Jobs CROMSOURCE - 51 Jobs IQVIA - 36 Jobs AstraZeneca - 36 Jobs Celgene - 32 Jobs IQVIA Biotech - 21 Jobs Oxford BioMedica (UK) Limited - 16 Jobs Lonza - 16 Jobs Grunenthal GmbH - 14 Jobs Register and Upload Your CV Now
All the biopharmaceutical companies must follow respective nation’s laws or regulations in order to develop, manufacture and sale their pharmaceutical products.
All the biopharmaceutical companies must follow respective nation’s laws or regulations in order to develop, manufacture and sale their pharmaceutical products. Before any biopharmaceutical product goes in to market, it has to get marketing authorization from the relevant health authorities. Market authorization is issued on the basis of an assessment of submitted information that describes the quality, safety and efficacy of the product for a specified indication. Applicants and manufacturers often implement changes in the product, production process, quality controls, equipment, facilities, responsible personnel, or labeling estab…
All the biopharmaceutical companies must follow respective nation’s laws or regulations in order to develop, manufacture and sale their pharmaceutical products. Before any biopharmaceutical product goes in to market, it has to get marketing authorization from the relevant health authorities. Market authorization is issued on the basis of an assessment of submitted information that describes the quality, safety and efficacy of the product for a specified indication. Applicants and manufacturers often implement changes in the product, production process, quality controls, equipment, facilities, responsible personnel, or labeling estab…
Herald Meetings brings forth International Conference on Nanotechnology and Nanomaterials the one which is going to takes place at most historic place in Europe Rome, Italy on March 02-03, 2020 brings together leading experts, scientists, researchers, engineers and policymakers in the field of Nanotechnology to Exchange information on the latest innovation and progress. Where you can Connect| Learn| Collaborate
Conference Brochure | Submit Abstract | Scientific Sessions Herald Meetings takes pleasure in inviting the scientific community across the globe to attend the International Conference on Nanotechnology and Nanomaterials during March 02-03, 2020 at Rome, Italy around the theme "Inquisition of Nanotechnology for better prospective" Why to Attend?? Nanotechnology 2020 Conf…
Conference Brochure | Submit Abstract | Scientific Sessions Herald Meetings takes pleasure in inviting the scientific community across the globe to attend the International Conference on Nanotechnology and Nanomaterials during March 02-03, 2020 at Rome, Italy around the theme "Inquisition of Nanotechnology for better prospective" Why to Attend?? Nanotechnology 2020 Conf…
30-Jul-2019
Hepatitis E is a liver disease caused by infection due to a virus known as hepatitis E virus (HEV). This disease can cause swelling in liver. Some of the common symptoms are mild fever, feeling of tiredness, feeling sick to stomach, and belly pain.
Hepatitis E is a liver disease caused by infection due to a virus known as hepatitis E virus (HEV). This disease can cause swelling in liver. Some of the common symptoms are mild fever, feeling of tiredness, feeling sick to stomach, and belly pain. Download the sample report at: https://www.pharmaproff.com/request-sample/1029 The World Health Organization (WHO) estimates released in 2018 stated that, every year, an estimated 20 million HEV infections worldwide, leading to an estimated 3.3 million symptomatic cases of hepatitis E. Although, this d…
Hepatitis E is a liver disease caused by infection due to a virus known as hepatitis E virus (HEV). This disease can cause swelling in liver. Some of the common symptoms are mild fever, feeling of tiredness, feeling sick to stomach, and belly pain. Download the sample report at: https://www.pharmaproff.com/request-sample/1029 The World Health Organization (WHO) estimates released in 2018 stated that, every year, an estimated 20 million HEV infections worldwide, leading to an estimated 3.3 million symptomatic cases of hepatitis E. Although, this d…
Leading immunoassay specialist, BBI Solutions, will demonstrate how its lateral flow software is making point-of-care testing (POCT) more accurate, efficient and easier to use than ever before at the world’s largest laboratory medicine tradeshow, AACC, this summer.
Leading immunoassay specialist, BBI Solutions, will demonstrate how its lateral flow software is making point-of-care testing (POCT) more accurate, efficient and easier to use than ever before at the world’s largest laboratory medicine tradeshow, American Association for Clinical Chemistry (AACC) exhibition, this summer. BBI’s mobile arm, Novarum™, will launch a demonstrator app that can read the results of an imitated malaria test on stand 4254 at the AACC Clinical Lab Expo, which runs from 4th-8th August in California. The app…
Leading immunoassay specialist, BBI Solutions, will demonstrate how its lateral flow software is making point-of-care testing (POCT) more accurate, efficient and easier to use than ever before at the world’s largest laboratory medicine tradeshow, American Association for Clinical Chemistry (AACC) exhibition, this summer. BBI’s mobile arm, Novarum™, will launch a demonstrator app that can read the results of an imitated malaria test on stand 4254 at the AACC Clinical Lab Expo, which runs from 4th-8th August in California. The app…
19-Jul-2019
As reported recently, in the last six years, nearly 600 GP surgeries have closed, affecting almost two million patients. The closures have been blamed on underfunding, under-resourcing and an ongoing recruitment crisis. Here, Oliver Pittock, managing director of healthcare consumables supplier Valley Northern, comments.
As reported recently, in the last six years, nearly 600 GP surgeries have closed, affecting almost two million patients. The closures have been blamed on underfunding, under-resourcing and an ongoing recruitment crisis. Here, Oliver Pittock, managing director of healthcare consumables supplier Valley Northern, comments. The coming years will be crucial for the NHS. It’s been suggested that in the next five years, the NHS could be short of 7,000 GP’s if the budget for traini…
As reported recently, in the last six years, nearly 600 GP surgeries have closed, affecting almost two million patients. The closures have been blamed on underfunding, under-resourcing and an ongoing recruitment crisis. Here, Oliver Pittock, managing director of healthcare consumables supplier Valley Northern, comments. The coming years will be crucial for the NHS. It’s been suggested that in the next five years, the NHS could be short of 7,000 GP’s if the budget for traini…
19-Jul-2019
According to a recent report, care home residents account for around 250,000 emergency hospital admissions each year. However, it’s estimated that 40 per cent of these admissions could be avoided with a better understanding of a resident’s health needs and the medication they consume. But what can be done to reduce this figure? Here, Adrian Pittock, marketing director of healthcare consumables supplier, Valley Northern, explains more.
According to a recent report, care home residents account for around 250,000 emergency hospital admissions each year. However, it’s estimated that 40 per cent of these admissions could be avoided with a better understanding of a resident’s health needs and the medication they consume. But what can be done to reduce this figure? Here, Adrian Pittock, marketing…
According to a recent report, care home residents account for around 250,000 emergency hospital admissions each year. However, it’s estimated that 40 per cent of these admissions could be avoided with a better understanding of a resident’s health needs and the medication they consume. But what can be done to reduce this figure? Here, Adrian Pittock, marketing…
From driverless cars being rolled out recently to robots performing surgeries, technology has surely made a stellar progress. One such example is medical robots. Medical robots are set to revolutionize the healthcare sector, especially surgeries, since they are becoming more and more acceptable, globally. They not only help in reducing the time of surgery but also ensure the accuracy of the whole process coupled with better quality of patient care, thereby increasing the demand for surgical robots across the globe.
The growth of the Medical Robots Market can be attributed to the issuance of IPOs by medical robot companies, advantages offered by robot-assisted training in rehabilitation therapy, growing hospital investments in medical robots, increasing funding for medical robot research, an…
The growth of the Medical Robots Market can be attributed to the issuance of IPOs by medical robot companies, advantages offered by robot-assisted training in rehabilitation therapy, growing hospital investments in medical robots, increasing funding for medical robot research, an…
Synthetic Biology Market Report, Added by Premium Market Insights, forecasts that the global market was valued to be $5.2 billion in 2015 and is expected to grow a CAGR of 23% during the period 2015 - 2020.
Nucleotide synthesis and sequencing technology segment would continue to lead the market until 2020. Synthetic oligos and software tools segment, collectively, held around half of the market share in 2015. Download Research SampleThe global synthetic biology market is poised to grow at a CAGR of 23% between 2015 to 2020 owing to its growing applications in drug & vaccine development, biofuel production and high demand for bio-based polymers & biochemical. Emerging applications across novel fields of research, such as agriculture and bioremediation are expected to further drive t…
Nucleotide synthesis and sequencing technology segment would continue to lead the market until 2020. Synthetic oligos and software tools segment, collectively, held around half of the market share in 2015. Download Research SampleThe global synthetic biology market is poised to grow at a CAGR of 23% between 2015 to 2020 owing to its growing applications in drug & vaccine development, biofuel production and high demand for bio-based polymers & biochemical. Emerging applications across novel fields of research, such as agriculture and bioremediation are expected to further drive t…
25-Jun-2019
Antibody drug conjugate (ADC) is a biologically active cytotoxic drug linked to a monoclonal antibody (mAb) by a chemical bond, and a monoclonal antibody (mAb) is used as a carrier to transport the cytotoxic drug to the target cells. This novel drug has brought a new trend in the field of cancer treatment and aroused interest of more and more people.
what is an antibody drug conjugate? Antibody drug conjugate (ADC) is a biologically active cytotoxic drug linked to a monoclonal antibody (mAb) by a chemical bond, and a monoclonal antibody (mAb) is used as a carrier to transport the cytotoxic drug to the target cells. This novel drug has brought a new trend in the field of cancer treatment and aroused interest of more and more people. So what are the features and history of ADCs and why are t…
what is an antibody drug conjugate? Antibody drug conjugate (ADC) is a biologically active cytotoxic drug linked to a monoclonal antibody (mAb) by a chemical bond, and a monoclonal antibody (mAb) is used as a carrier to transport the cytotoxic drug to the target cells. This novel drug has brought a new trend in the field of cancer treatment and aroused interest of more and more people. So what are the features and history of ADCs and why are t…
Many of us don’t like to think about death, in fact, we avoid the subject where possible. Banishing the taboo around death is important, as, after all, we are all going to die someday, so why aren’t we more open about discussing it?
Many of us don’t like to think about death, in fact, we avoid the subject where possible. Banishing the taboo around death is important, as, after all, we are all going to die someday, so why aren’t we more open about discussing it? The more we talk about death, the easier it will be to normalise the subject and feel less fearful of the unknown. Whether you want to talk about it or not, one aspect of death that you can’t hide from is deciding what you want to happen to your body when you pass. It’s not a particularly pleasant thought but it is one you’ll eventua…
Many of us don’t like to think about death, in fact, we avoid the subject where possible. Banishing the taboo around death is important, as, after all, we are all going to die someday, so why aren’t we more open about discussing it? The more we talk about death, the easier it will be to normalise the subject and feel less fearful of the unknown. Whether you want to talk about it or not, one aspect of death that you can’t hide from is deciding what you want to happen to your body when you pass. It’s not a particularly pleasant thought but it is one you’ll eventua…
On 30 March, at the fourth annual Talking About Diabetes event, a host of celebrities, athletes, patients and healthcare professionals took to the stage to share their inspirational stories of living with and managing type 1 diabetes.
On 30 March, at the fourth annual Talking About Diabetes event, a host of celebrities, athletes, patients and healthcare professionals took to the stage to share their inspirational stories of living with and managing type 1 diabetes. Through a series of talks, the speakers provided fresh perspectives on living with type 1 diabetes, whilst experts in the area provided insights on the importance of removing barriers and embracing new technologies. Novo Nordisk UK is a key sponsor of the event, which took place at the Royal College of Physicians, London. Actor…
On 30 March, at the fourth annual Talking About Diabetes event, a host of celebrities, athletes, patients and healthcare professionals took to the stage to share their inspirational stories of living with and managing type 1 diabetes. Through a series of talks, the speakers provided fresh perspectives on living with type 1 diabetes, whilst experts in the area provided insights on the importance of removing barriers and embracing new technologies. Novo Nordisk UK is a key sponsor of the event, which took place at the Royal College of Physicians, London. Actor…
22-Jul-2019
Regulatory Careers Live is the only one-day careers fair in Europe dedicated to regulatory affairs. Our careers fair is for anyone who is starting or looking to further their career in healthcare regulatory affairs no matter where they are in the profession. It is an opportunity to meet with potential future employers and get essential advice from some of the most respected and influential leaders in the field of regulatory affairs
21 May 2019 | University of Hertfordshire, Hatfield, UKRegulatory Careers Live is the only one-day careers fair in Europe dedicated to regulatory affairs. Our careers fair is for anyone who is starting or looking to further their career in healthcare regulatory affairs no matter where they are in the profession. It is an opportunity to meet with potential future…
21 May 2019 | University of Hertfordshire, Hatfield, UKRegulatory Careers Live is the only one-day careers fair in Europe dedicated to regulatory affairs. Our careers fair is for anyone who is starting or looking to further their career in healthcare regulatory affairs no matter where they are in the profession. It is an opportunity to meet with potential future…
Whatever the industry, digital transformation creates an opportunity for teams to connect to the fuller insights they need, on demand – which in turn can help to drive substantial improvements to productivity, accuracy and efficiency.
Whatever the industry, digital transformation creates an opportunity for teams to connect to the fuller insights they need, on demand – which in turn can help to drive substantial improvements to productivity, accuracy and efficiency. One of the main potential beneficiaries of improved information management in life sciences is Regulatory Affairs – a department which must prepare and manage data ad infinitum, to keep products on the market. Here, ProductLife Group’s Erick Gaussens sets out three persuasive reasons why RA teams should champion the digital trans…
Whatever the industry, digital transformation creates an opportunity for teams to connect to the fuller insights they need, on demand – which in turn can help to drive substantial improvements to productivity, accuracy and efficiency. One of the main potential beneficiaries of improved information management in life sciences is Regulatory Affairs – a department which must prepare and manage data ad infinitum, to keep products on the market. Here, ProductLife Group’s Erick Gaussens sets out three persuasive reasons why RA teams should champion the digital trans…
